<h4>Background</h4>Functional visual outcomes in macular edema (ME) secondary to retinal vein occlusion (RVO) after the anti-vascular endothelial growth factor (VEGF) loading phase are highly variable. This evidence concerns the gene VEGFA and retinal vein occlusion.